138 - Retrospective study assessing safety of pediatric dental moderate sedation medications

Retrospective study assessing safety of pediatric dental moderate sedation medications

Hubrecht A, Unkel JH, Berry EJ

Bon Secours St Mary’s Hospital of Richmond

Purpose: The purpose of this study was to assess the safety profile of pediatric moderate sedation medications including midazolam, triazolam, ketamine, dexmedetomidine, hydroxyzine, dexmedetomidine with midazolam, and versed with hydroxyzine, all paired with nitrous oxide.

Methods: This retrospective chart review involved 943 pediatric patients that completed moderate sedation for dental treatment at Bon Secours Pediatric Dental residency from June 2014 to November 2024. Demographic data, medication regimen, route of administration, ASA status, medical history, sedation level, sedation behavior, and adverse events where recorded. The Tracking and Reporting Outcomes of Procedural Sedation (TROOPS) and Pediatric sedation state scale (PSSS) were used to assess and categorize adverse events for each sedation.

Results: The mean age of all participants was 6.39 years with 50.2% female and 49.2% male. No major events were found with the TROOPS and PSSS scales. Final data pending.

Conclusions:  The TROOPS and PSSS scales did not find any major adverse events with the moderate sedation regimens in this study. Final data pending.

Identify Supporting Agency and Grant Number: